New hope for Tough-to-Treat colitis flares
NCT ID NCT06420492
Summary
This study is testing a new oral drug called BRS201 for adults experiencing a severe flare-up of ulcerative colitis who haven't gotten better with steroid treatment. Over 12 weeks, participants will take the study drug for 4 weeks and have several clinic visits for check-ups and tests. The main goal is to see if the drug can reduce inflammation and improve symptoms in these difficult cases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
NOT_YET_RECRUITINGChestnut Hill, Massachusetts, 02467, United States
-
Brigham and Women's Hospital
RECRUITINGChestnut Hill, Massachusetts, 02467, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.